Stay updated with breaking news from Regulatory Authorization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
![Inovio Pharmaceuticals Inc. [INO] stock Downgrade by BofA Securities analyst, price target now $8 - Vimarsana News](https://dbtnews.com/wp-content/uploads/2020/01/Image-154.png)
Inovio Pharmaceuticals Inc. [NASDAQ: INO] plunged by -$0.38 during the normal trading session on Thursday and reaching a high of $7.41 during the day while it closed the day at $7.08. The company report on November 3, 2021 that INOVIO Further Expands INNOVATE Phase 3 Trial for COVID-19 DNA Vaccine C
Inovio Pharmaceuticals Inc. (INO) is priced at $7.39 after the most recent trading session. At the very opening of the session, the stock price was $7.80 and reached a high price of $7.90, prior to closing the session it reached the value of $7.77. The stock touched a low price of $7.69.Recently in
Hyderabad’s Biological E set to give fourth vaccine for India By M Somasekhar| Updated: 23rd April 2021 9:13 pm IST M Somasekhar Hyderabad: Biological E, the country’s first manufacturer of vaccines in the private sector is all set to launch India’s fourth vaccine against COVID 19 by August 2021. According to the Indian Council of Medical Research( ICMR) , Biological E is testing a two-dose vaccine similar to ‘Covaxin’, made by Bharat Biotech, another Hyderabad -based, vaccine maker. The Niti Aayog member (health) Dr V K Paul recently said, “Biological E has finished phase-1/2 ...
Read more about United States to help India's Biological E make 1 billion vaccine doses on Business Standard. The so-called Quad group agreed to expand efforts to ramp up vaccine manufacturing in the region
Johnson & Johnson has been issued an emergency use listing by the WHO for the Janssen single-shot COVID-19 vaccine.